Naitive Technologies
About Naitive Technologies
Naitive Technologies is a medical technology company leveraging AI-driven software to transform orthopedic care, with a primary focus on musculoskeletal health. Their mission is to address critical challenges in this field by developing intelligent, pathway-driven technologies. These solutions are designed to assist orthopedic providers in identifying at-risk patients earlier, facilitating their conversion to appropriate treatment, and coordinating their care throughout their journey. [1, 5, 7]
The company’s flagship product, OsteoSight™, exemplifies this mission by enabling the opportunistic assessment of low bone mineral density (BMD) from routine X-rays. [1, 5, 6] This technology seamlessly integrates bone health assessment into the orthopedic care pathway, aiming to drive earlier intervention, enable more informed surgical planning, and reduce osteoporotic fractures. Naitive’s approach is built on academic leadership from institutions like Oxford and Cambridge, in collaboration with world-leading healthcare systems, to deliver explainable, reproducible, and clinically impactful AI solutions. [1, 5, 6]
Focus Areas
Business Intelligence
| Key Investors | Mercia Ventures |
| Partnerships | Parvizi Surgical Innovation (PSI), Heraeus Medical, Utah Orthopaedics, Joint Implant Surgeons (JIS) Research Institute, Pre-Competitive Consortium on Osteoporosis and Bone Health (PRECCO) |
| Technology | AI-driven software as a Medical Device (SaMD), proprietary image processing pipeline, computer vision, machine learning, opportunistic assessment of bone mineral density (BMD) from routine X-rays, cloud-native and on-premise deployment options |
| FDA Clearances | 1 cleared products (estimated) |
What Physicians Need to Know
Naitive Technologies stands out for physicians by offering a solution that seamlessly integrates into existing orthopedic workflows, utilizing routine X-rays to opportunistically identify patients at risk of low bone mineral density without requiring additional appointments or equipment. This leads to earlier detection and intervention for osteoporosis, which can significantly improve patient outcomes, reduce fracture risk, and enable more informed surgical planning. The FDA 510(k) clearance and Breakthrough Device designation of OsteoSight provide a strong validation of its diagnostic accuracy and clinical utility, building trust in the AI-driven insights. Furthermore, Naitive's approach helps practices identify more eligible patients, potentially expanding services and generating new revenue opportunities in bone health management. Their commitment to building a comprehensive bone health platform from 'Image to Intervention' aims to support physicians in managing the entire care pathway more effectively.
Naitive's OsteoSight operates via integration with a host integration platform that facilitates the secure transfer of DICOM images and associated metadata from existing clinical imaging systems. While specific EHR/EMR integrations for OsteoSight are not explicitly detailed in all search results, Naitive's broader AI consulting arm mentions capabilities for integration with major EHR/EMR systems (Athena, Epic, NextGen, Kareo, DrChrono), patient portals (MyChart, Healow), PMS scheduling (AdvancedMD, Kareo, Modernizing Medicine), and pharmacy systems, indicating a strong understanding and potential for comprehensive healthcare system connectivity.
What the Web Says
Naitive Technologies appears to be a medical technology company focused on AI-driven software for orthopedic care, with their flagship product, OsteoSight, recently receiving FDA 510(k) clearance for opportunistic bone health assessment using X-rays. While specific product reviews for OsteoSight are not yet widely available due to its recent clearance, the company's mission is to redefine care delivery by driving earlier intervention and improving surgical planning. Employer reviews for companies with similar names like 'NAIVE' and 'Navi Technologies' on platforms like Indeed and Reddit show a mixed to negative sentiment, often citing issues with management, pay, and work-life balance. It's important to distinguish Naitive Technologies from these similarly named companies when evaluating employer sentiment.
Overall: MixedStrengths
- AI-driven software for orthopedic care (OsteoSight).
- OsteoSight received FDA 510(k) clearance.
- Aims to improve patient outcomes and surgical planning.
- Potential for earlier intervention in osteoporosis detection.
- Built on academic leadership from Oxford and Cambridge.
- Focus on proactive bone health platform.
Limitations
- Lack of specific product reviews for Naitive Technologies' OsteoSight due to recent clearance.
- Employer reviews for similarly named companies (NAIVE, Navi Technologies) indicate poor management.
- Issues with pay and benefits reported by employees of similarly named companies.
- Concerns about work-life balance in similarly named companies.
- Lack of growth opportunities in similarly named companies.
- Negative experiences with HR and termination processes in similarly named companies.
Based on reviews from: PR Newswire, Indeed.com, Reddit
Last updated: 2026-07-18
Videos
News, demos, and interviews about Naitive Technologies.
Videos load interactively. If none appear, search YouTube for Naitive Technologies →
Press & Coverage
Frequently Asked Questions
Related Companies
Precision Medical Ventures, Inc. Dba Revealdx (RevealDx) is a Seattle-based healthcare AI company focused on dramatically improving lung cancer outcomes through non-invasive diagnosis. They develop advanced, radiomics and AI-enabled, lung cancer decision support software. Their flagship product, RevealAI-Lung, is a Computer-Assisted Diagnostic (CADx) software that analyzes patient lung computed tomography (CT) images to provide information […]
SafeBeat Rx is a healthcare AI company focused on transforming cardiac care by expanding access to remote patient monitoring (RPM), continuous telemetry, event monitoring, and software-enabled remote therapeutic monitoring (RTM). The company’s core offering is an integrated technology that utilizes automated artificial intelligence-based software to analyze electrocardiogram (ECG) data. This technology is designed to replace […]
Measure Labs, Inc., operating as PreemptiveAI, Inc., is a healthcare AI company focused on transforming healthcare from reactive disease management to proactive risk identification and prevention. The company has developed a “revolutionary” foundation model, a large-scale machine learning model, that interprets biomedical signals from smartphones and wearable devices to predict health outcomes in real-time. This […]
EarliPoint Health, formerly EarliTec Diagnostics, is a healthcare AI company dedicated to transforming autism care through innovative, FDA-cleared eye-tracking technology. The company’s core product, the EarliPoint System, is a medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months through 95 months (7 […]
Onera B.V., operating as Onera Health, is a Dutch med-tech company that is transforming sleep diagnostics and monitoring with its innovative, self-applied, no-wire polysomnography (PSG) solution. [12, 19] Founded as a spin-off from the imec research center, a leader in nanoelectronics and digital technologies, Onera aims to make clinical-grade sleep studies broadly accessible, convenient, and […]
Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]